Photodynamic therapy combined with antivascular endothelial growth factor treatment for recalcitrant chronic central serous chorioretinopathy

Masumi G Asahi1 Clinical Research Department, Retina Macula Institute, Torrance, CA, USA

Andrew T Chon1 Clinical Research Department, Retina Macula Institute, Torrance, CA, USA

Esmeralda Gallemore1 Clinical Research Department, Retina Macula Institute, Torrance, CA, USA

Ron P Gallemore1 Clinical Research Department, Retina Macula Institute, Torrance, CA, USA;2 Jules Stein Eye Institute, University of California, Los Angeles, CA, USACorrespondence[email protected]

Pages 2051-2056 | Published online: 21 Nov 2017

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

IaconoPParodiMBFalcomataBBandelloFCentral serous chorioretinopathy treatments: a mini reviewOphthalmic Res20165527684
Web of Science ®Google Scholar
LevineRBruckerAJRobinsonFLong-term follow-up of idiopathic central serous chorioretinopathy by fluorescein angiographyOphthalmology19899668548592740080
PubMed Web of Science ®Google Scholar
NicholsonBNobleJForooghianFMeyerleCCentral serous chorioretinopathy: update on pathophysiology and treatmentSurv Ophthalmol201358210312623410821
PubMed Web of Science ®Google Scholar
FungATYannuzziLAFreundKBType 1 (sub-retinal pigment epithelial) neovascularization in central serous chorioretinopathy masquerading as neovascular age-related macular degenerationRetina20123291829183722850219
PubMed Web of Science ®Google Scholar
DaruichAMatetADiraniACentral serous chorioretinopathy: recent findings and new physiopathology hypothesisProg Retin Eye Res2015488211826026923
PubMed Web of Science ®Google Scholar
ChanWMLaiTYLaiRYLiuDTLamDSHalf-dose verteporfin photodynamic therapy for acute central serous chorioretinopathy: one-year results of a randomized controlled trialOphthalmology2008115101756176518538401
PubMed Web of Science ®Google Scholar
ReibaldiMBosciaFAvitabileTLow-fluence photodynamic therapy in longstanding chronic central serous chorioretinopathy with foveal and gravitational atrophyEur J Ophthalmol200919115415819123167
PubMed Web of Science ®Google Scholar
MaJMengNXuXZhouFQuYSystem review and meta-analysis on photodynamic therapy in central serous chorioretinopathyActa Ophthalmol2014928e594e60125042260
PubMed Web of Science ®Google Scholar
MehanySShaukatAMMohamedFSMouradKMRole of Avastin in management of central serous chorioretinopathySaudi J Ophthalmol2010243697523960879
PubMedGoogle Scholar
ChungYRSeoEJLewHMLeeKHLack of positive effect of intravitreal bevacizumab in central serous chorioretinopathy: meta-analysis and reviewEye201327121339134624202051
PubMed Web of Science ®Google Scholar
KurtzDCarlsonNBClinical Procedures of Ocular Examination3rd editionNew YorkMcGraw-Hill2003
Google Scholar
WangMSSanderBLarsenMRetinal atrophy in idiopathic central serous chorioretinopathyAm J Ophthalmol2002133678779312036670
PubMed Web of Science ®Google Scholar
SpaideRFCampeasLHaasACentral serous chorioretinopathy in younger and older adultsOphthalmology199610312207020799003341
PubMed Web of Science ®Google Scholar
ErikitolaOCCrosby-NwaobiRLoteryAJSivaprasadSPhotodynamic therapy for central serous chorioretinopathyEye (Lond)201428894495724946843
PubMed Web of Science ®Google Scholar
LeePYKimKSLeeWKSevere choroidal ischemia following photodynamic therapy for pigment epithelial detachment and chronic central serous chorioretinopathyJpn J Ophthalmol2009531525619184311
PubMed Web of Science ®Google Scholar
NicoloMEandiCMAlovisiCHalf-fluence versus half-dose photodynamic therapy in chronic central serous chorioretinopathyAm J Ophthalmol201415751033103724487046
PubMed Web of Science ®Google Scholar
RouvasAStavarkasPTheodossiadisPGLong-term results of half-fluence photodynamic therapy for chronic central serous chorioretinopathyEur J Ophthalmol201222341742221928269
PubMed Web of Science ®Google Scholar
LaiTYYWongRLMChanWLong-term outcomes of half-dose verteporfin photodynamic therapy for the treatment of central serous chorioretinopathy (An American Ophthalmological Society Thesis)Trans Am Ophthalmol Soc2015113T826755855
PubMedGoogle Scholar
InoueMKadanosonoKWatanabeYKobayashiSYamaneSArakawaAResults of one-year follow-up examinations after intravitreal bevacizumab administration for chronic central serous chorioretinopathyOphthalmologica20112251374020693820
PubMed Web of Science ®Google Scholar
SmretschnigEHagenSGlittenbergCIntravitreal anti-vascular endothelial growth factor combined with half-fluence photodynamic therapy for choroidal neovascularization in chronic central serous chorioretinopathyEye (Lond)201630680581126965012
PubMed Web of Science ®Google Scholar
XuYTanCSSafety and complications of intravitreal injections performed in an Asian population in SingaporeInt Ophthalmol201637232533227236451
PubMed Web of Science ®Google Scholar
UetaniRItoYOiwaKIshikawaKTeriyakiHHalf dose vs one-third-dose photodynamic therapy for chronic central serous chorioretinopathyEye (Lond)201226564064922573069
PubMed Web of Science ®Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Photodynamic therapy combined with antivascular endothelial growth factor treatment for recalcitrant chronic central serous chorioretinopathy

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Photodynamic therapy combined with antivascular endothelial growth factor treatment for recalcitrant chronic central serous chorioretinopathy

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date